RT Journal Article
SR Electronic
T1 Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 232
OP 252
DO 10.3174/ajnr.A1461
VO 30
IS 2
A1 Mittal, S.
A1 Wu, Z.
A1 Neelavalli, J.
A1 Haacke, E.M.
YR 2009
UL http://www.ajnr.org/content/30/2/232.abstract
AB SUMMARY: Susceptibility-weighted imaging (SWI) has continued to develop into a powerful clinical tool to visualize venous structures and iron in the brain and to study diverse pathologic conditions. SWI offers a unique contrast, different from spin attenuation, T1, T2, and T2* (see Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1). In this clinical review (Part 2), we present a variety of neurovascular and neurodegenerative disease applications for SWI, covering trauma, stroke, cerebral amyloid angiopathy, venous anomalies, multiple sclerosis, and tumors. We conclude that SWI often offers complementary information valuable in the diagnosis and potential treatment of patients with neurologic disorders.